Your molecule, Our mission - Company Brochure

After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies. 

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. With over 40 years of experience and a growing team of over 2,400 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. 

East Rutherford, NJ – May 31, 2023 – Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, invitro diagnosis companies, hospitals and universities with analytical services for blood investigations and hemocompatibility testing.

Active ingredients, Dynamic people - From laboratory scale to commercial supply, enjoy working with the experts at Cambrex on your API.

Drug formulations, Expertly finished - From pre-formulation registration batches and clinical supply to commercial manufacturing and packaging, Cambrex delivers your complex dosage forms with expertise.

Analytical solutions, Quality assured - Trust our analytical development and testing experts to rapidly advance your molecule for the greatest chance of success.